Dr Khurram Muhammad Baig, DO | |
190 Campus Blvd Ste 300, Winchester, VA 22601-2872 | |
(540) 667-1244 | |
(540) 667-3086 |
Full Name | Dr Khurram Muhammad Baig |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 13 Years |
Location | 190 Campus Blvd Ste 300, Winchester, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568753002 | NPI | - | NPPES |
1568753002 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 0102205877 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Winchester Medical Center | Winchester, VA | Hospital |
Shenandoah Memorial Hospital | Woodstock, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Winchester Gastroenterology Associates | 6608762851 | 15 |
News Archive
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
US Oncology, Inc., the nation's leading integrated oncology company, today announced its new iKnowMed™ Technology Platform to support community oncologists nationwide. This new platform enhances cancer care quality and practice efficiency through integrated, oncology-specific technologies that enable community oncologists to solve challenges in the areas of care delivery, drug management, and revenue cycle management.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
Researchers at Boston University School of Medicine have identified clinical characteristics associated with prescription drug use disorder in primary care patients with chronic pain. The study found that by identifying characteristics of prescription drug abuse, primary care clinicians can identify those at risk and provide appropriate treatment.
› Verified 8 days ago
Entity Name | Winchester Gastroenterology Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740248525 PECOS PAC ID: 6608762851 Enrollment ID: O20040224001255 |
News Archive
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
US Oncology, Inc., the nation's leading integrated oncology company, today announced its new iKnowMed™ Technology Platform to support community oncologists nationwide. This new platform enhances cancer care quality and practice efficiency through integrated, oncology-specific technologies that enable community oncologists to solve challenges in the areas of care delivery, drug management, and revenue cycle management.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
Researchers at Boston University School of Medicine have identified clinical characteristics associated with prescription drug use disorder in primary care patients with chronic pain. The study found that by identifying characteristics of prescription drug abuse, primary care clinicians can identify those at risk and provide appropriate treatment.
› Verified 8 days ago
Entity Name | Augusta Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245489590 PECOS PAC ID: 3678632544 Enrollment ID: O20081106000590 |
News Archive
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
US Oncology, Inc., the nation's leading integrated oncology company, today announced its new iKnowMed™ Technology Platform to support community oncologists nationwide. This new platform enhances cancer care quality and practice efficiency through integrated, oncology-specific technologies that enable community oncologists to solve challenges in the areas of care delivery, drug management, and revenue cycle management.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
Researchers at Boston University School of Medicine have identified clinical characteristics associated with prescription drug use disorder in primary care patients with chronic pain. The study found that by identifying characteristics of prescription drug abuse, primary care clinicians can identify those at risk and provide appropriate treatment.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Khurram Muhammad Baig, DO 190 Campus Blvd Ste 300, Winchester, VA 22601-2872 Ph: (540) 667-1244 | Dr Khurram Muhammad Baig, DO 190 Campus Blvd Ste 300, Winchester, VA 22601-2872 Ph: (540) 667-1244 |
News Archive
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
US Oncology, Inc., the nation's leading integrated oncology company, today announced its new iKnowMed™ Technology Platform to support community oncologists nationwide. This new platform enhances cancer care quality and practice efficiency through integrated, oncology-specific technologies that enable community oncologists to solve challenges in the areas of care delivery, drug management, and revenue cycle management.
SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal "Cell Reports" aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.
Researchers at Boston University School of Medicine have identified clinical characteristics associated with prescription drug use disorder in primary care patients with chronic pain. The study found that by identifying characteristics of prescription drug abuse, primary care clinicians can identify those at risk and provide appropriate treatment.
› Verified 8 days ago
Dr. Raveen Chawla, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Neal S Gaither, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Lee Resta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 400 Campus Blvd Ste 100, Winchester, VA 22601 Phone: 540-662-1108 | |
Kristine Gade Reed, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 400 Campus Blvd., Suite 100, Winchester, VA 22601 Phone: 540-662-1108 Fax: 540-450-2244 | |
Dr. David Jack Lecronier, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 190 Campus Blvd Ste 201, Winchester, VA 22601 Phone: 540-536-5980 Fax: 540-536-5979 | |
T. Glen Bouder, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8874 Fax: 540-536-7847 | |
Dr. Manish J Lakhani, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 |